Back to top

Image: Bigstock

Cerebras Drops 20% in a Month: Is the Stock a Buy on the Dip?

Read MoreHide Full Article

Key Takeaways

  • CBRS shares fell 20.4% in a month amid OpenAI capacity delays, margin pressure & rising infrastructure costs.
  • CBRS' Q3 core revenues surged 70% to $230.9M, while cloud services revenues jumped 272% to $144.9M.
  • CBRS expects revenues to triple in 2027, backed by hyperscaler partnerships and growing AI inference demand.

Cerebras Systems (CBRS - Free Report) shares have dropped 20.4% in the past month, reflecting investor concerns over its OpenAI partnership, delays in AI data center capacity deployment, margin pressure and elevated infrastructure investments. The company continues to face stiff competition from NVIDIA (NVDA - Free Report) , Advanced Micro Devices (AMD - Free Report) and Intel (INTC - Free Report) in the AI space. However, strong demand for high-speed AI inference, expanding hyperscaler relationships and improving financial guidance suggest that the recent weakness could present a long-term buying opportunity. So, what should investors do with the stock? Let’s dig deep to find out.

CBRS’ Prospects Suffer From Data Center Delays

Concerns surrounding Cerebras’ relationship with OpenAI have been a major overhang on its shares. During the third-quarter 2026 earnings call, Cerebras acknowledged that insufficient data center capacity prevented a broader rollout of OpenAI’s Ultrafast offerings. CBRS management, however, rejected speculation that technical limitations were responsible and reiterated that OpenAI remains an important customer. The company disclosed delays in delivering portions of the contracted 750 megawatts of inference capacity, primarily due to land, power and building infrastructure constraints. Cerebras expects to return to its planned delivery schedule by the second half of 2027. 

Profitability remains another concern for Cerebras. Despite reporting record third-quarter 2026 revenues, GAAP gross margin contracted to 20% from 40.6% in the year-ago quarter, reflecting a weaker hardware margin profile and accounting adjustments. Core hardware gross margin was 31%, pressured by shipments under older, lower-priced contracts. Meanwhile, the company reported a GAAP net loss of $161.2 million compared with $22.2 million in the prior-year quarter.

Cerebras’ prospects are suffering from stiff competition from the likes of NVIDIA (NVDA - Free Report) , Advanced Micro Devices (AMD - Free Report) and Intel (INTC - Free Report) in the AI space. NVIDIA is dominating the AI GPU market through its Blackwell, Hopper and DGX/NVL systems that are used for AI training and inference. AMD’s MI300 and MI350 accelerator families are competing with CBRS in hyperscale AI infrastructure and enterprise AI clusters. Meanwhile, Intel’s Gaudi AI accelerators target enterprise AI training and inference as a lower-cost GPU alternative. Shares of AMD, NVIDIA and Intel have dropped 0.8%, 30.2% and 40.4%, respectively, over the past month.

CBRS Stock’s Price Performance

 

Zacks Investment Research
Image Source: Zacks Investment Research

 

Cerebras shares are also trading at a premium, as suggested by the Value Score of D.

Moreover, Wall Street’s consensus price target implies roughly 143.04% average upside from current levels.

 

 

Zacks Investment Research
Image Source: Zacks Investment Research

 

Robust AI Inference Demand Aids CBRS’ Prospects

Cerebras continues to benefit from accelerating demand for high-speed AI inference solutions. In the third quarter of 2026, core revenues surged 70% year over year to $230.9 million, exceeding the company’s guidance midpoint by approximately 7%. Core cloud and other services revenues jumped 272% to $144.9 million, highlighting growing adoption of its inference platform. CBRS raised its fourth-quarter core revenue guidance to the $310-$330 million range and 2026 forecast to the $940-$960 million range. Cerebras also expects revenues to triple in 2027, supported by expanding cloud capacity, hardware shipments and stronger customer demand.

Cerebras’ expanding relationships with major cloud providers strengthen its long-term growth prospects and could reduce dependence on individual customers. The company secured partnerships with Amazon Web Services, Oracle and Microsoft, representing three hyperscaler wins over six months. Oracle plans to integrate Cerebras’ high-speed inference technology into Oracle Cloud Infrastructure, with service availability expected in summer 2027. Microsoft has also signed a cloud agreement, with additional details expected in 2027. Cerebras indicated that its opportunity pipeline increased by more than tenfold during the third quarter.

Cerebras’ expanding product portfolio and differentiated wafer-scale computing architecture remain important competitive advantages. The company’s CS-4 AI accelerator is approaching full production and is expected to double the performance and throughput of CS-3. The next-generation CS-5 system, powered by Wafer Scale Engine 5, is targeted for production in early summer 2027 and is designed to deliver more than twice the speed of CS-4. Cerebras has also introduced production-scale heterogeneous disaggregated inference using AMD GPUs alongside its proprietary systems. CBRS estimates that this architecture can increase token generation by up to fivefold per megawatt, potentially improving inference economics and data center profitability. Unlike competing GPU architectures, Cerebras’ systems do not require high-bandwidth memory, reducing exposure to memory shortages and associated cost inflation.

CBRS’ Estimate Revisions Show Improving Trend

The Zacks Consensus Estimate for CBRS’ 2026 earnings is pegged at 12 cents per share, against a loss of 36 cents per share over the past 30 days. 

The consensus mark for fourth-quarter 2026 loss is pegged at 1 cent per share compared with a loss of 20 cents per share over the past 30 days.

Consensus Estimate Trend

 

Zacks Investment Research
Image Source: Zacks Investment Research

 

Conclusion: Here’s Why You Should Buy CBRS Stock

Cerebras’ recent share-price weakness reflects legitimate concerns over OpenAI capacity delivery delays, customer concentration, substantial infrastructure spending and persistent GAAP losses. These factors could sustain near-term volatility. Nevertheless, accelerating AI inference demand, growing hyperscaler adoption, expanding infrastructure capacity and an improving core profitability outlook provide a compelling long-term growth narrative. The company's differentiated technology and expectations of tripling revenues in 2027 strengthen the investment case. For investors comfortable with elevated execution and valuation risks, the recent pullback could represent an attractive opportunity to gain exposure to the expanding AI inference market.

Cerebras currently has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Published in